Artivion, Inc. (NYSE:AORT) SVP and General Counsel Jean F. Holloway has sold a total of 979 shares of the company's common stock on May 9, 2024, for a total transaction value of $23,285. The shares were sold at a price of $23.785 each, according to a recent SEC filing.
The transaction has resulted in Holloway's direct ownership in Artivion, Inc. being adjusted to 168,732 shares following the sale. The reported sale price reflects the value at which the shares were disposed of, as noted in the footnotes of the SEC filing.
Artivion, Inc., formerly known as CryoLife Inc, is a company based in Kennesaw, Georgia, specializing in surgical and medical instruments and apparatus. The company's stock is traded under the ticker symbol AORT.
Investors often keep a close watch on insider transactions as they can provide insights into how the company's executives view the stock's value and future prospects. However, it is important to consider that insider sales may occur for various reasons and may not necessarily reflect a negative outlook on the company's performance.
The details of the transaction were made public through the SEC Form 4 filing, which is a requirement for company insiders to report changes in their company stock ownership.
InvestingPro Insights
Following the recent insider transaction at Artivion, Inc. (NYSE:AORT), where SVP and General Counsel Jean F. Holloway sold shares, investors may be seeking additional context to gauge the company's financial health and future prospects. Artivion, Inc. has shown a significant return over the last week, with a 1 Week Price Total Return of 11.8%. This uptick is part of a broader trend, as the company has also experienced a strong return over the last three months, with a 3 Month Price Total Return of 36.36%, and an impressive 58.0% return over the past year.
Despite not being profitable over the last twelve months, Artivion's revenue growth has been robust, with a Revenue Growth of 15.13% in the last twelve months as of Q1 2024. This is complemented by a Gross Profit Margin of 64.75%, indicating that while the company may be facing challenges to profitability, it is still generating a significant amount of gross profit relative to its revenue.
Analysts have mixed views on the company's future earnings, with some expecting net income to grow this year, while two analysts have revised their earnings downwards for the upcoming period. This suggests that while there is optimism about the company's earning potential, there are also reservations that could influence investor sentiment.
InvestingPro Tips for Artivion, Inc. highlight that the company has raised its dividend for 4 consecutive years, indicating a commitment to returning value to shareholders. However, it's important to note that the company is currently trading at a high EBITDA valuation multiple, which may suggest that the stock is priced optimistically relative to its earnings before interest, taxes, depreciation, and amortization.
For those interested in a deeper dive into Artivion, Inc.'s financials and performance metrics, InvestingPro offers additional insights. To explore these, along with further InvestingPro Tips, visit https://www.investing.com/pro/AORT. And remember, you can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. Artivion, Inc. has a total of 14 InvestingPro Tips listed on InvestingPro, providing a comprehensive analysis for informed investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.